Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria

International Journal of Experimental Pathology

Volumn 88, Issue 3, 2007, Pages 155-164

  Marcinkiewicz, J ^a   Ciszek, M ^a   Bobek, M ^a   Strus, M ^a   Heczko, P B ^a   Kurnyta, M ^a   Biedron R ^a   Chmielarczyk, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Colitis; Cytokines; Haeme oxygenase 1; Lactobacilli; Macrophages; Probiotics; Reactive oxygen species

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE; PROBIOTIC AGENT; PROTEIN P40; PROTEIN P70; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IMMUNOREGULATION; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ANIMALIS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS REUTERI; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

ANIMALS; CELLS, CULTURED; COLITIS; CYTOKINES; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HEME OXYGENASE-1; LACTOBACILLUS; LUMINESCENCE; MACROPHAGES; MICE; MICE, INBRED CBA; NITRIC OXIDE; PHAGOCYTOSIS; PROBIOTICS; REACTIVE OXYGEN SPECIES; SPECIES SPECIFICITY;

EID: 34248390080     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2007.00530.x     Document Type: Article

References (48)

1. Albrecht D. Jungi T.W. (1993) Luminol-enhanced chemiluminescence induced peripheral blood-derived human phagocytes: obligatory requirement of myeloperoxidase endocytosis by monocytes. J. Leukoc. Biol. 54, 300 306.
2. Balish Warner T.E. (2002) Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160, 2253 2257.
3. Baumgart D.C. Dignass A.U. (2002) Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care 5, 685 694.
4. Becker C., Dornhoff H., Neufert C. et al. (2006) Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177, 2760 2764.
5. Bibiloni R., Fedorak R.N., Tannock G.W. et al. (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539 1546.
6. Borruel N., Carol M., Casellas F. et al. (2002) Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51, 659 664.
7. Bousvaros A., Guandalini S., Baldassano R.N. et al. (2005) A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel. Dis. 11, 833 839.
8. Caballero-Franco C., Keller K., De Simone C., Chadee K. (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver. Physiol. 292, G315 G322.
9. Cario E. (2005) Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 54, 1182 1193.
10. Christensen H.R., Frokiaer H., Pestka J.J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171 178.
11. Cross M.L., Ganner A., Teilab D., Fray L.M. (2004) Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol. Med. Microbiol. 42, 173 180.
12. Darfeuille-Michaud A., Boudeau J., Bulois P. et al. (2004) High prevalence of adherent- invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412 421.
13. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. (2005) Probiotics ameliorate recurrent Th1- mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174, 3237 3246.
14. Dijkstra G., Moshage H., Jansen P.L. (2002) Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease Scand. J. Gastroenterol. Suppl. 236, 37 41.
15. Ding A.H., Nathan C.F., Stuehr D.J. (1988) Release of reactive nitrogen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407 2412.
16. Frankenberg L., Brugna M., Hederstedt L. (2002) Enterococcus faecalis heme-dependent catalase. J. Bacteriol. 184, 6351 6356.
17. Fuss I.J., Becker C., Yang Z. et al. (2006) Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel. Dis. 12, 9 15.
18. Hart A.L., Lammers K., Brigide P. et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602 1609.
19. Hart A.L., Al-Hassi H.O., Rigby R.J. et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50 65.
20. Kamada N., Hisamatsu T., Okamoto S. et al. (2005) Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol. 175, 6900 6908.
21. Kapturczak M.H., Wasserfall C., Brusko T. et al. (2004) Heme oxygenase-1 modulates early inflammatory responses. Evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165, 1045 1053.
22. Korhonen R., Korpela R., Saxelin M., Maki M., Kankaanranta H., Moilanen E. (2001) Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation 25, 223 232.
23. Kruidenier L., Kuiper I., Lamers C.B., Vespaget H.W. (2003) Intestinal oxidative in inflammatory bowel disease: semi-quantification, localization and association with mucosal antioxidants. J. Pathol. 201, 28 36.
24. Lee T.S. Chau L.Y. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240 246.
25. Luyer M.D, Wim A., Hadfoune M. et al. (2006) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun. 73, 3686 3692.
26. Manzoni P., Mostert M., Leonessa M.L. et al. (2006) Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis. 42, 1735 1742.
27. Marcinkiewicz J. Olszanecki R. (2004) Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids 27, 29 35.
28. Marcinkiewicz J., Grabowska A., Bereta J., Bryniarski K., Nowak B. (1998) Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacol. 40, 27 38.
29. Matsuguchi T., Takagi A., Matsuzaki T., et al. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol. 10, 259 266.
30. Matsumoto S., Hara T., Hori T. et al. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140, 417 426.
31. Niers L.E., Timmerman H.M., Rijkers G.T. et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin. Exp. Allergy 35, 1481 1489.
32. Ogura Y., Bonen D.K., Inohara N. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603 606.
33. Pena J.A., Li S.Y., Wilson P.H., Thibodeau S.A., Szary A.J., Versalovic J. (2004) Genotypic and phenotypic studies of intestinal lactobacilli: species differences in mice with and without colitis. Appl. Environ. Microbiol. 70, 558 568.
34. Podolsky D.K. (1991) Inflammatory bowel disease. N. Engl. J. Med. 325, 928 937.
35. Rachmilewitz D., Karmeli F., Takabayashi K. et al. (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428 1441.
36. Rath H.C. (2003) The role of endogenous bacterial flora: bystander or the necessary prerequisite?. Eur. J. Gastroenterol. Hepatol. 15, 615 620.
37. Rudolph U., Finegold M.J., Rich S.S. et al. (1995) Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10, 143 150.
38. Sartor R.B. (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 2, 5S 11S (review).
39. Sartor R.B. (2005) Probiotic therapy of intestinal inflammation and infections. Curr. Opin. Gastroenterol. 21, 44 50.
40. Schmidt C., Giese T., Ludwig B. et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm. Bowel. Dis. 11, 16 23.
41. Shanahan F. (2004) Probiotics in inflammatory bowel disease-therapeutic rationale and role. Adv. Drug. Deliv. Rev. 56, 809 818.
42. Sherman P.M., Johnson-Henry K.C., Yeung H.P. et al. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 73, 5183 5188.
43. Stallmach A., Marth T., Weiss B. et al. (2004) An interleukin 12p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. Gut 53, 339 345.
44. Strus M., Uhlig H., Powrie F. et al. (2005) A role of bacteria in inflammatory bowel disease evoked in animal models. Gastroenterol. Pol. 12, 15 20.
45. Uehara K., Takahashi T., Fujii H. et al. (2005) The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit. Care. Med. 33, 381 390.
46. Vidal K., Donnet-Hughes A., Granato D. (2002) Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and Gram-negative bacteria. Infect. Immun. 70, 2057 2064.
47. Wang W.P., Guo X., Koo M.W. et al. (2001) Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G586 G594.
48. Xu J. Verstraete W. (2001) Evaluation of nitric oxide production by lactobacilli. Appl Microbiol. Biotechnol. 56, 504 507.